Annual CFF
-$218.20M$207.45M+48.74%
Summary
- Current Value
- As of today, BIO annual cash from financing is -$218.20M, up +48.74% on
- Historical Performance
- BIO annual cash from financing is down -293.66% over the past 3 years, and down -858.78% over the past 5 years
- All-Time High Comparison
- BIO annual cash from financing is currently -122.41% below its historical high of $973.58M set on
- 3-Year Low Comparison
- BIO annual cash from financing is +48.74% above its 3-year low of -$425.65M reached on
- Sector Comparison
- BIO annual cash from financing is higher than 8.14% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$218.20M | +48.7% | -293.7% | -858.8% | -174.2% | |
| Quarterly Cash From Financing | -$52.50M | +45.3% | -498.5% | -10000.0% | -1831.5% | |
| TTM Cash From Financing | -$312.77M | +20.3% | -129.4% | -195.2% | -3617.0% | |
| Price | $324.09 | -5.8% | -22.6% | -48.5% | +208.4% | |
| Annual Cash From Operations | $454.60M | +21.3% | +209.4% | -0.7% | +39.9% | |
| Annual Cash From Investing | -$160.20M | -892.8% | +79.9% | +23.3% | +8.9% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $1.38B | -2.2% | +486.7% | +111.2% | +85.1% | |
| Shares Outstanding | 26.97M | -3.7% | -8.9% | -9.6% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $973.58M | N/A | -122.4% |
| 5Y | $973.58M | -122.4% | |
| All | $973.58M | -122.4% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$425.65M | +48.7% | |
| 5Y | -$523.04M | N/A | +58.3% |
| All | -$523.04M | +58.3% |
Cash From Financing History
FAQ
What is the current annual cash from financing of BIO?
As of today, BIO annual cash from financing is -$218.20M
What is 1-year change in BIO annual cash from financing?
BIO annual cash from financing is up +48.74% year-over-year
What is 3-year change in BIO annual cash from financing?
BIO annual cash from financing is down -293.66% over the past 3 years
How far is BIO annual cash from financing from its all-time high?
BIO annual cash from financing is currently -122.41% below its historical high of $973.58M set on December 31, 2022
How does BIO annual cash from financing rank versus sector peers?
BIO annual cash from financing is higher than 8.14% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly CFF
-$52.50M$83.80M+61.48%
Summary
- Current Value
- As of today, BIO quarterly cash from financing is -$52.50M, up +61.48% on
- Historical Performance
- BIO quarterly cash from financing is up +45.30% year-over-year, and down -498.50% over the past 3 years
- All-Time High Comparison
- BIO quarterly cash from financing is currently -104.41% below its historical high of $1.19B set on
- 3-Year Low Comparison
- BIO quarterly cash from financing is +74.10% above its 3-year low of -$202.74M reached on
- Sector Comparison
- BIO quarterly cash from financing is higher than 8.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$52.50M | +61.5% | +45.3% | -498.5% | -10000.0% | |
| Annual Cash From Financing | -$218.20M | – | +48.7% | -293.7% | -858.8% | |
| TTM Cash From Financing | -$312.77M | +12.2% | +20.3% | -129.4% | -195.2% | |
| Price | $324.09 | +9.3% | -5.8% | -22.6% | -48.5% | |
| Quarterly Cash From Operations | $120.90M | +3.8% | -26.1% | +109.0% | +155.7% | |
| Quarterly Cash From Investing | -$43.00M | +62.7% | +22.7% | +51.4% | -147.3% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $1.40B | -0.8% | +0.5% | +0.4% | +112.4% | |
| Shares Outstanding | 26.97M | – | -3.7% | -8.9% | -9.6% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$26.27M | N/A | -99.9% |
| 3Y | $4.31M | -1318.4% | |
| 5Y | $1.19B | -104.4% | |
| All | $1.19B | -104.4% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$136.30M | +61.5% | |
| 3Y | -$202.74M | +74.1% | |
| 5Y | -$421.88M | N/A | +87.6% |
| All | -$421.88M | +87.6% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of BIO?
As of today, BIO quarterly cash from financing is -$52.50M
What is BIO quarterly cash from financing most recent change?
BIO quarterly cash from financing was up +61.48% on September 30, 2025
What is 1-year change in BIO quarterly cash from financing?
BIO quarterly cash from financing is up +45.30% year-over-year
How far is BIO quarterly cash from financing from its all-time high?
BIO quarterly cash from financing is currently -104.41% below its historical high of $1.19B set on March 31, 2022
How does BIO quarterly cash from financing rank versus sector peers?
BIO quarterly cash from financing is higher than 8.61% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM CFF
-$312.77M$43.49M+12.21%
Summary
- Current Value
- As of today, BIO TTM cash from financing is -$312.77M, up +12.21% on
- Historical Performance
- BIO TTM cash from financing is up +20.33% year-over-year, and down -129.37% over the past 3 years
- All-Time High Comparison
- BIO TTM cash from financing is currently -126.46% below its historical high of $1.18B set on
- 3-Year Low Comparison
- BIO TTM cash from financing is +27.15% above its 3-year low of -$429.32M reached on
- Sector Comparison
- BIO TTM cash from financing is higher than 7.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$312.77M | +12.2% | +20.3% | -129.4% | -195.2% | |
| Annual Cash From Financing | -$218.20M | – | +48.7% | -293.7% | -858.8% | |
| Quarterly Cash From Financing | -$52.50M | +61.5% | +45.3% | -498.5% | -10000.0% | |
| Price | $324.09 | +9.3% | -5.8% | -22.6% | -48.5% | |
| TTM Cash From Operations | $491.47M | -8.0% | +19.4% | +161.5% | +244.7% | |
| TTM Cash From Investing | -$186.04M | +6.4% | -223.8% | +89.2% | -160.8% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $1.40B | -0.8% | +0.5% | +0.4% | +112.4% | |
| Shares Outstanding | 26.97M | – | -3.7% | -8.9% | -9.6% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$218.20M | N/A | -43.3% |
| 3Y | $973.58M | N/A | -132.1% |
| 5Y | $1.18B | -126.5% | |
| All | $1.18B | -126.5% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$356.25M | +12.2% | |
| 3Y | -$429.32M | +27.1% | |
| 5Y | -$523.04M | N/A | +40.2% |
| All | -$523.04M | +40.2% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of BIO?
As of today, BIO TTM cash from financing is -$312.77M
What is BIO TTM cash from financing most recent change?
BIO TTM cash from financing was up +12.21% on September 30, 2025
What is 1-year change in BIO TTM cash from financing?
BIO TTM cash from financing is up +20.33% year-over-year
How far is BIO TTM cash from financing from its all-time high?
BIO TTM cash from financing is currently -126.46% below its historical high of $1.18B set on March 31, 2022
How does BIO TTM cash from financing rank versus sector peers?
BIO TTM cash from financing is higher than 7.89% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio